ACC Action Center
Welcome to the ACC Action Center, bringing you the latest updates from the American College of Cardiology’s Annual Scientific Session & Expo, hosted in partnership with the World Congress of Cardiology. This collection will highlight emerging clinical data and explore the latest practice-changing advances in the field of cardiology.
Rivaroxaban as effective as warfarin for left ventricular thrombus post-MI
ACC Action CenterRivaroxaban as effective as warfarin for left ventricular thrombus post-MI
Mobile integrated health program in patients with HF
ACC Action CenterMobile integrated health program in patients with HF
Phase 3 study with oral semaglutide meets primary endpoint in high-risk T2D
ACC Action CenterPhase 3 study with oral semaglutide meets primary endpoint in high-risk T2D
Low-dose apixaban noninferior to full dose in cancer-associated VTE
ACC Action CenterLow-dose apixaban noninferior to full dose in cancer-associated VTE
AI model may accelerate risk stratification of coronary revascularization in ED
ACC Action CenterAI model may accelerate risk stratification of coronary revascularization in ED
- advertisement
- 05/16/2025
- 05/15/2025
- 05/15/2025
- 05/14/2025
- 05/13/2025
- 05/12/2025